Quest Diagnostics Incorporated
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical …
Medical - Diagnostics & Research
US, Secaucus [HQ]
Financials
Analysts
Wall Street · Earnings · Institutional SentimentA comprehensive analysis section that covers unveiling insights about Quest Diagnostics Incorporated's gradings, price targets and earnings estimates.
Earnings
See the historical earnings and what wall street
analysts forecasted and
forecast for
future earnings.
Reported
Past Estimate Consensus
Future Estimate Consensus
| FY | EPS | Revenue [mil.] | Profit [mil.] | EBITDA [mil.] | EBIT [mil.] | Expenses · SGA [mil.] | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| E | E | E | E | E | E | |||||||
| 2014 | 5.5800 | 4.020 | 7,146 | 7,378 | 849 | 548 | 1,316 | 1,286 | 1,001 | 972 | 1,704 | 1,800 |
| 2015 | 3.8300 | 4.771 | 7,435 | 7,494 | 556 | 701 | 1,327 | 1,520 | 983 | 1,381 | 1,728 | 1,752 |
| 2016 | 4.9200 | 5.101 | 7,493 | 7,510 | 709 | 633 | 1,560 | 1,443 | 1,065 | 1,257 | 1,679 | 1,713 |
| 2017 | 4.5800 | 5.648 | 7,515 | 7,708 | 645 | 725 | 1,360 | 1,341 | 1,159 | 1,087 | 1,681 | 1,705 |
| 2018 | 5.6300 | 6.334 | 7,709 | 7,570 | 772 | 734 | 1,451 | 1,393 | 1,165 | 1,098 | 1,750 | 1,497 |
| 2019 | 5.4100 | 6.495 | 7,531 | 7,718 | 736 | 829 | 1,406 | 1,559 | 1,105 | 1,189 | 1,424 | 1,410 |
| 2020 | 6.3800 | 10.799 | 7,726 | 9,342 | 858 | 1,303 | 1,580 | 2,212 | 1,231 | 1,802 | 1,457 | 1,469 |
| 2021 | 10.6800 | 14.117 | 9,437 | 10,740 | 1,431 | 1,712 | 2,408 | 2,709 | 1,971 | 2,044 | 1,550 | 1,493 |
| 2022 | 15.9000 | 9.848 | 10,788 | 9,829 | 1,995 | 1,306 | 3,158 | 2,219 | 2,381 | 1,852 | 1,727 | 1,573 |
| 2023 | 8.1200 | 8.711 | 9,883 | 9,216 | 946 | 850 | 1,810 | 2,440 | 1,428 | 2,037 | 1,874 | 1,731 |
| 2024 | 7.5900 | 8.901 | 9,252 | 9,819 | 854 | 1,005 | 1,790 | 2,217 | 1,351 | 1,804 | 1,610 | 1,721 |
| 2025 | - | 9.724 | - | 10,688 | - | 1,093 | - | 2,413 | - | 1,963 | - | 1,873 |
| 2026 | - | 10.568 | - | 11,100 | - | 2.F12X/td> | - | 2.F121/td> | - | 2.F121 | - | 2.F121 |
| 2027 | - | 11.510 | - | 11,582 | - | 1.F13X/td> | - | 1.F131/td> | - | 1.F131 | - | 1.F131 |
| 2028 | - | 12.600 | - | 12,055 | - | 0.F14X/td> | - | 0.F141/td> | - | 0.F141 | - | 0.F141 |
Institutional Sentiment
Wall Street · Earnings · Institutional Sentiment
Morgan Stanley
1Y Ago:
n/a
Prev. Grade
n/a
Latest
n/a
JP Morgan Chase
1Y Ago:
Equal-Weight
Prev. Grade
Equal-Weight
Nov. 6, 2024
Equal-Weight
Citigroup
1Y Ago:
Underweight
Prev. Grade
Equal-Weight
Nov. 6, 2024
Equal-Weight
Overall Consensus
Grading Consensus
Click to each, to see the gradePrice Target Consensus
-3.215% $5.26 · MISS
Nov. 6, 2024Price Then
$154.10
Price Target
$168.85
Price Now
$163.59